Fas/Fas ligand expression and induction of apoptosis in chondrocytes

Arthritis and Rheumatism

Volumn 40, Issue 10, 1997, Pages 1749-1755

  Hashimoto, Sanshiro ^a   Setareh, Morteza ^a   Ochs, Robert L ^a   Lotz, Martin ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTIBODY; FAS ANTIGEN; LIGAND; MESSENGER RNA; NITRIC OXIDE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL SUBPOPULATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; OSTEOARTHRITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; FAS LIGAND PROTEIN; HUMANS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, ELECTRON; NITRIC OXIDE; OSTEOARTHRITIS; REFERENCE VALUES; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0030854379     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780401004     Document Type: Article

References (26)

1. Hamerman D: Clinical implications of osteoarthritis and ageing. Ann Rheum Dis 54:82-85, 1995
2. Abyad A, Boyer JT: Arthritis and aging. Curr Opin Rheumatol 4:153-159, 1992
3. Sokoloff L: Ageing and degenerative diseases affecting cartilage. In, Cartilage, Biomedical Aspects. Edited by BK Hall. New York, Academic Press, 1983
4. Vignon E, Arlot M, Patricot LM, Vignon G: The cell density of human femoral head cartilage. Clin Orthop 121:303-308, 1976
5. Lotz M, Setareh M, von Kempis J, Schwarz H: The nerve growth factor/tumor necrosis factor receptor family. J Leukoc Biol 60:1-7, 1996
6. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
7. Suda T, Takahashi T, Golstein P: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1165-1178, 1993
8. Shyr-Te J, Panka JD, Cui H: Fas (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373:444-448, 1995
9. Watanabe-Fukunaga R, Brannan CI, Copeland NC: The cDNA structure, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279, 1992
10. Lynch DH, Watson ML, Alderson MR: The mouse Fas ligand gene is mutated in gld mice and is pari of a TNF family gene cluster. Immunity 1:131-136, 1994
11. Hiramatsu TN: Imunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19:1354-1359, 1994
12. Galle PR, Hofmann WJ, Walczak H: Involvement of CD95 receptor and ligand in liver damage. J Exp Med 182:1223-1230, 1995
13. Ogasawara J, Watanabe-Fukunaga R, Adachi M: Lethal effects of the anti-Fas antibody in mice. Nature 363:806-809, 1993
14. Tsuboi M, Eguchi K, Kawakami A: Fas antigen expression on synovial cells was down-regulated by interleukin 1 beta. Biochem Biophys Res Commun 218:280-285, 1996
15. Firestein GS, Yeo M, Zvaifler NJ: Apoptosis in rheumatoid arthritis synovium. J Clin Invest 96:1631-1638, 1995
16. Hoa T, Hasunuma T, Aono H: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23:1332-1337, 1996
17. Villiger PM, Lotz M: Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO J 11:135-143, 1992
18. Blanco FJ, Ochs RL, Schwarz H, Lotz M: Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146:75-85, 1995
19. Stockwell RA: The interrelationship of cell density and cartilage thickness in mammalian articular cartilage. J Anat 109:411-421, 1971
20. Aydelotte MB, Kuettner KE: Differences between sub-populations of cultured bovine articular chondrocytes. I. Morphology and cartilage matrix production. Connect Tissue Res 18:205-222, 1988
21. Hayashi T, Abe E. Jasin HE: Fibronectin synthesis in superficial and deep layers of normal articular cartilage. Arthritis Rheum 39:567-573, 1996
22. Takagi T, Jasin HE: Interactions of synovial fluid immunoglobulins with chondrocytes. Arthritis Rheum 35:1502-1509, 1992
23. Häuselmann HJ, Flechtenmacher J, Michal L, Thonar EJ-MA, Shinmei M, Kuettner KE, Aydelotte MB: The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers. Arthritis Rheum 39:478-488, 1996
24. Hayashi T, Abe E, Yamate T, Taguchi Y, Jasin HE: Nitric oxide production by superficial and deep articular chondrocytes. Arthritis Rheum 40:261-269, 1997
25. Blanco FJ, Lotz M: IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res 218:319-325, 1995
26. Fujisawa K, Asahara H, Okamoto K: Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest 98:271-278, 1996